Menu

Tesla, Southwest, Apple, AMC and more

Funviralpark 2 years ago 0 3

A sign is displayed in front of the AMC Theater in Chicago, Illinois on January 27, 2021. AMC Entertainment’s stock more than quadrupled today as investors continue to buy shares that have been severely shorted.

Scott Olson | Getty Images

Check out the companies in the spotlight on the midday deal.

Tesla – Electric vehicle shares are up more than 3% after being sold in 10 of the last 11 trading sessions. Baird also lowered its price target on the stock to $252 from $316.

Southwest Airlines – Airline shares fell 2.5% as they continued to run shortened schedules. Southwest Airlines canceled 60% of its scheduled flights on Wednesday, while rival airlines Limited fares to help stranded travelers.

AMC Entertainment – AMC Entertainment’s stock fell about 3% after a day CEO Adam Aron tweeted that he asked the company’s board of directors. It has frozen salaries for 2023 and urged other executives to refrain from raising salaries.

Generak — Equipment makers are up 5% following the start of purchases of Janie Montgomery Scott. The company has set a price target of $160. That means he’s up 75.5% since Tuesday’s close.

Nio — Shares of electric car makers fell 2%. That’s based on Tuesday’s 8% slide after announcing fourth-quarter production cuts due to the Covid outbreak.

Energy Stocks – A range of energy companies fell as oil and gas prices fell. EQT fell more than 6%, APA 3.6% decrease, cotera 3.5% decrease. These three stocks made him one of the S&P 500’s biggest losers in intraday trading.

maxion — Stocks fell 8% after the solar company announced that Bill Mulligan would become its new CEO. Previously, he was the Chief Operating Officer of Sila Nanotechnologies.

apple — Stocks of tech giants fell 1.5%. The stock has fallen for the past three days, hitting a 52-week low on Wednesday.

IDEAYABioscience — IDEAYA added nearly 5% following the start of an overweight from Capital One Securities. The company has set a price target of $29. That’s up 75.4% for him over Tuesday’s close.

Kara Pharmaceutical — The biopharmaceutical company experienced rapid growth of more than 200% after the Food and Drug Administration approved an investigational New Drug Application as a potential treatment for persistent corneal epithelial defects.

— CNBC’s Samantha Subin, Tanaya Macheel, and Sarah Min contributed to the report

– Advertisement – BuzzMag Ad
Written By

Leave a Reply

Leave a Reply

Your email address will not be published. Required fields are marked *

– Advertisement – BuzzMag Ad